Does Choral Singing Help imprOve Stress in Patients With Ischemic HeaRt Disease?
- Conditions
- Coronary Heart DiseaseIschemic Heart DiseaseMyocardial Infarction
- Interventions
- Behavioral: Choral Singing
- Registration Number
- NCT03076801
- Lead Sponsor
- Nova Scotia Health Authority
- Brief Summary
This pilot randomized control trial will examine the role of choral singing on psychosocial stress and cardiovascular outcomes in patients with ischemic heart disease (IHD). The hypothesis is that choral singing will improve psychosocial stress in comparison to the control group and this may have an impact on rates of hospitalization, death, myocardial infarction and stroke in these patients.
- Detailed Description
Objectives:
The purpose of this pilot study is to examine the impact of choral singing on psychosocial stress and major cardiovascular events in patients with IHD in comparison to usual medical care.
Recruitment and Randomization:
Participants will be recruited from community cardiac rehabilitation programs with recruitment presentations, phone calls and mailed invitations. Interested participants will complete baseline questionnaires and provide consent. They will be randomly allocated to either the intervention or control group. Stratification by past or present experience in organized singing (as a binary variable, yes or no) will be used.
Baseline Assessment:
All participants will undergo a baseline assessment, comprised of biophysical characteristics and medical history; level of physical activity self reported by International Physical Activity Questionnaire (IPAQ) long form; assessment of music appreciation and current participation in group singing; and three questionnaires measuring psychosocial stress: the Perceived Stress Scale (PSS), Hospital Anxiety and Depression Scale (HADS) and the Standard Form - 36 (SF - 36).
Intervention:
Participants in the intervention group will participate in weekly 60-90 minute singing sessions led by professional musicians over a 12-week period. Sessions will begin with a 5-minute physical warm-up of gentle stretching and a 5-minute vocal warm-up. Music will be selected from a variety of genres and eras. Attendance will be taken weekly.
Control:
The control group will receive usual medical care. If control group participants join a singing group during the study period they will not be excluded, but this data will be collected and considered.
Analysis:
Data analysis will be done blind with respect to participant allocation. Analysis will include and account for attendance or adherence to consider dose response. Only participants who have attended at least 50% of group singing sessions will be included. A sub-group comparison between those who have attended 50-74% of sessions and those who have attended ≥75% will be done to determine if there is a dose-response effect to the weekly singing sessions. Participants who join another singing group during or after the intervention period will not be excluded, but this will be taken into account. The concept of music "responders" and "non-responders" will be considered based on the initial screening question "How important is music in your day-to-day life?".
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 16
- Participants must have a history of myocardial infarction or acute coronary syndrome and have undergone cardiac rehabilitation. All levels of musical ability and past experience will be included.
- Participants unable to respond to English questionnaires will be excluded.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Choral Singing Intervention Choral Singing In addition to usual medical care, participants in the intervention group will participate in choral singing.
- Primary Outcome Measures
Name Time Method Psychosocial Stress Baseline, 3 months and 6 months Change in a composite measure of stress from baseline to 3 months and 6 months is the Primary Outcome Measure. This composite measure of stress is comprised of of the Perceived Stress Scale (PSS), Hospital Anxiety and Depression Scale (HADS) and the Standard Form - 36 (SF - 36). Individual scores for the three scales will be determined for each participant at baseline, 3 and 6 months. These scores will be converted to the same scale and averaged with each component weighted equally to determine the composite stress score for each participant.
- Secondary Outcome Measures
Name Time Method Rate of hospitalization. 12 months Rates of hospitalization over 12 months will be determined by chart review.
Rates of death. 12 months Rates of death over 12 months will be determined by chart review.
Rates of myocardial infarction . 12 months Rates of myocardial infarction over 12 months will be determined by chart review.
Rates of stroke. 12 months Rates of stroke over 12 months will be determined by chart review.
Intervention adherence 3 months Weekly attendance will be taken for participants in the intervention arm.
Trial Locations
- Locations (1)
Heart and Lung Wellness Centre
🇨🇦Sydney, Nova Scotia, Canada